|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00455 TIANDA PHARMA
Nominal 
0.190 +0.005 (+2.703%) | 2023/12 - Final HKD(K$) | 2022/12 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | (49,757) | 76,428 | (8,225) | (37,635) | (19,902) |
| Net Cash from / (used in) Investing Activities | (69,101) | (9,608) | 86,350 | (137,733) | (41,065) |
| Net Cash from / (used in) Financing Activities | (57,394) | (28,890) | (1,295) | 90,753 | (812) |
| Increase / (Decrease) in Cash & Cash Equivalents | (176,252) | 37,930 | 76,830 | (84,614) | (61,779) |
| Cash & Cash Equivalents at beginning of period | 340,277 | 334,002 | 248,247 | 311,963 | 393,168 |
| Effect of Foreign Exchange Rate Changes | (1,583) | (31,655) | 8,925 | 20,899 | (19,426) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 162,442 | 340,277 | 334,002 | 248,247 | 311,963 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -27,236,000 |
| %Change | 559.947% |
| EPS / (LPS) | HKD -0.013 |
| NBV Per Share ($) | HKD 0.253 |